1-1 of 1
Xuedong Chi
Close
Sort by
Journal Articles

Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphoma

Clinical Trials & Observations
Ajay K. Gopal, Robert Chen, Scott E. Smith, Stephen M. Ansell, Joseph D. Rosenblatt, Kerry J. Savage, Joseph M. Connors, Andreas Engert, Emily K. Larsen, Xuedong Chi, Eric L. Sievers, Anas Younes
Journal: Blood
Blood (2015) 125 (8): 1236–1243.
https://doi.org/10.1182/blood-2014-08-595801
Published: 2015
Includes: Supplemental data